Texas Instruments SVP sells 6,125 shares after exercise

Texas Instruments executive Katharine Kane reported option exercises and share sales in company stock.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Texas Instruments executive Katharine Kane reported option exercises and share sales in company stock. On April 27, 2026, she exercised options for 6,125 shares of common stock at strike prices of $174.8100 and $130.5200 per share and acquired the underlying shares.

That same day, she sold 4,175 shares at a weighted average price of about $270.0862 and 1,950 shares at about $271.1145 in open‑market transactions. Following these transactions, she directly holds 25,212 shares of Texas Instruments common stock.

Insider Trade Summary

Exercise and Sale: 6,125 shares ($634K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Kane Katharine

Role SVP and General Counsel

Sold 6,125 shs ($1.66M)

Approx. gross sale proceeds $1.66M

Approx. exercise cost $1.02M

Approx. pre-tax spread $634K

Type	Security	Shares	Price	Value
Exercise	NQ Stock Option (Right to Buy)	1,100	$0.00	$0.00
Exercise	NQ Stock Option (Right to Buy)	5,025	$0.00	$0.00
Exercise	Common Stock	1,100	$130.52	$144K
Exercise	Common Stock	5,025	$174.81	$878K
Sale	Common Stock	4,175	$270.0862	$1.13M
Sale	Common Stock	1,950	$271.1145	$529K

Holdings After Transaction: NQ Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 25,212 shares (Direct)

Footnotes (4)

F1. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $269.54 to $270.372. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F2. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $270.875 to $271.28. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F3. The option became exercisable in four equal annual installments beginning on January 24, 2021.
F4. The option became exercisable in four equal annual installments beginning on January 27, 2023.

Key Figures

Shares sold: 6,125 shares First sale block: 4,175 shares at $270.0862 Second sale block: 1,950 shares at $271.1145 +3 more

6 metrics

Shares sold 6,125 shares Total common stock sold on April 27, 2026

First sale block 4,175 shares at $270.0862 Weighted average price for open‑market sale

Second sale block 1,950 shares at $271.1145 Weighted average price for open‑market sale

Options exercised 5,025 shares at $174.8100 NQ stock option exercise into common shares

Additional options exercised 1,100 shares at $130.5200 NQ stock option exercise into common shares

Post-transaction holdings 25,212 shares Directly owned common stock after transactions

Key Terms

NQ Stock Option (Right to Buy), weighted average sale price, non-derivative, Exercise or conversion of derivative security

4 terms

NQ Stock Option (Right to Buy) financial

"security_title: "NQ Stock Option (Right to Buy)" with underlying common stock"

weighted average sale price financial

"The price in Table 1 is a weighted average sale price."

non-derivative financial

"transaction_type": "non-derivative" for common stock entries"

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Texas Instruments (TXN) executive Katharine Kane report in this Form 4 filing?

Katharine Kane reported exercising stock options for 6,125 Texas Instruments shares and selling 6,125 shares in open‑market trades. The transactions occurred on April 27, 2026, and reflect routine executive equity activity combining option exercises with share dispositions.

How many Texas Instruments (TXN) shares did Katharine Kane sell and at what prices?

Kane sold 4,175 Texas Instruments common shares at a weighted average price of about $270.0862 and 1,950 shares at about $271.1145. The sales were open‑market transactions with actual prices ranging within narrow ranges around those averages.

What stock options did Katharine Kane exercise in this Texas Instruments (TXN) Form 4?

She exercised nonqualified stock options covering 5,025 shares at a $174.8100 exercise price and 1,100 shares at a $130.5200 exercise price. These options had become exercisable in four equal annual installments beginning in 2021 and 2023, respectively, according to the filing footnotes.

How many Texas Instruments (TXN) shares does Katharine Kane own after these transactions?

After the reported option exercises and sales, Katharine Kane directly holds 25,212 shares of Texas Instruments common stock. This figure comes from the post‑transaction ownership reported for her last listed non‑derivative holding entry in the Form 4 filing.

Were the sale prices in Katharine Kane’s Texas Instruments (TXN) trades fixed or averaged?

The reported sale prices are weighted averages for multiple trades. Footnotes state the 4,175‑share sale was executed between $269.54 and $270.372, and the 1,950‑share sale between $270.875 and $271.28, with detailed trade breakdowns available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/28/2026 - 04:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kane Katharine

(Last)

(First)

(Middle)

12500 TI BOULEVARD

(Street)

DALLAS

TEXAS

75243

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEXAS INSTRUMENTS INC [ TXN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP and General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/27/2026		M		1,100	A	$130.52	26,312	D
Common Stock	04/27/2026		M		5,025	A	$174.81	31,337	D
Common Stock	04/27/2026		S		4,175⁽¹⁾	D	$270.0862	27,162	D
Common Stock	04/27/2026		S		1,950⁽²⁾	D	$271.1145	25,212	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
NQ Stock Option (Right to Buy)	$130.52	04/27/2026		M			1,100	⁽³⁾	01/24/2030	Common Stock	1,100	$0	0	D
NQ Stock Option (Right to Buy)	$174.81	04/27/2026		M			5,025	⁽⁴⁾	01/27/2032	Common Stock	5,025	$0	0	D

Explanation of Responses:

1. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $269.54 to $270.372. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

2. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $270.875 to $271.28. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

3. The option became exercisable in four equal annual installments beginning on January 24, 2021.

4. The option became exercisable in four equal annual installments beginning on January 27, 2023.

Remarks:

	/s/ Shannon Thompson, Attorney in Fact	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR